| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
126,890,000 |
| Market
Cap: |
1.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$9.07 - $9.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies for blood-related cancers where there is an unmet medical need. Co. has one commercially approved product, VONJO™ (pacritinib), which has received approval in the U.S. by the U.S. Food and Drug Administration for the treatment of adult patients with intermediate or primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 x 10^9/L.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
5,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$27,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
9,840,628 |
| Total Sell Value |
$0 |
$0 |
$0 |
$60,171,858 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
25 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bauer John H |
Director |
– • – |
2009-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
498,130 |
|
- |
|
| Philips Craig |
President |
• – – |
2009-09-25 |
4 |
S |
$1.24 |
$262,450 |
D/D |
(211,500) |
2,460,899 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2009-09-25 |
4 |
S |
$1.23 |
$129,889 |
D/D |
(105,580) |
1,417,105 |
|
- |
|
| Eramian Daniel G |
EVP, Corporate Communications |
• – – |
2009-09-25 |
4 |
S |
$1.25 |
$130,345 |
D/D |
(104,276) |
1,269,955 |
|
- |
|
| Singer Jack W |
EVP, Chief Medical Officer |
• • – |
2009-09-25 |
4 |
AS |
$1.23 |
$124,722 |
D/D |
(101,380) |
1,425,683 |
|
- |
|
| Bianco James A |
CEO |
• • – |
2009-09-25 |
4 |
AS |
$1.19 |
$379,733 |
D/D |
(318,621) |
2,814,739 |
|
- |
|
| Bianco James A |
CEO |
• • – |
2009-09-11 |
4 |
S |
$1.43 |
$1,953,534 |
D/D |
(1,366,108) |
3,133,360 |
|
- |
|
| Nudelman Phillip M Phd |
Director |
– • – |
2009-08-14 |
4 |
S |
$1.57 |
$257,480 |
D/D |
(164,000) |
701,281 |
|
- |
|
| Love Richard L |
Director |
– • – |
2009-08-12 |
4 |
S |
$1.64 |
$114,800 |
D/D |
(70,000) |
547,405 |
|
- |
|
| Bauer John H |
Director |
– • – |
2009-08-10 |
4 |
S |
$1.50 |
$120,000 |
D/D |
(80,000) |
478,130 |
|
- |
|
| Eramian Daniel G |
EVP, Corporate Communications |
• – – |
2009-07-31 |
4/A |
D |
$1.48 |
$347,895 |
D/D |
(235,064) |
1,374,231 |
|
- |
|
| Eramian Daniel G |
EVP, Corporate Communications |
• – – |
2009-07-31 |
4 |
D |
$1.48 |
$347,895 |
D/D |
(235,064) |
964,398 |
|
- |
|
| Eramian Daniel G |
EVP, Corporate Communications |
• – – |
2009-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
644,897 |
1,609,295 |
|
- |
|
| Singer Jack W |
EVP, Chief Medical Officer |
• – – |
2009-07-31 |
4 |
D |
$1.48 |
$472,557 |
D/D |
(319,295) |
1,527,063 |
|
- |
|
| Singer Jack W |
EVP, Chief Medical Officer |
• – – |
2009-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
875,981 |
1,846,358 |
|
- |
|
| Telling Fred |
Director |
– • – |
2009-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
214,966 |
583,068 |
|
- |
|
| Nudelman Phillip M Phd |
Director |
– • – |
2009-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
322,449 |
865,281 |
|
- |
|
| Philips Craig |
President |
• – – |
2009-07-31 |
4 |
D |
$1.48 |
$695,792 |
D/D |
(470,130) |
2,672,399 |
|
- |
|
| Philips Craig |
President |
• – – |
2009-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,289,795 |
3,142,529 |
|
- |
|
| Mundinger Mary Oneil |
Director |
– • – |
2009-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
214,966 |
568,171 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2009-07-31 |
4 |
D |
$1.48 |
$472,557 |
D/D |
(319,295) |
1,522,685 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2009-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
875,981 |
1,841,980 |
|
- |
|
| Gregorian Vartan |
Director |
– • – |
2009-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
214,966 |
583,255 |
|
- |
|
| Bauer John H |
Director |
– • – |
2009-06-02 |
4 |
S |
$1.76 |
$44,000 |
D/D |
(25,000) |
343,164 |
|
- |
|
| Love Richard L |
Director |
– • – |
2009-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
321,839 |
402,439 |
|
- |
|
742 Records found
|
|
Page 22 of 30 |
|
|
